Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Rizwana ParveenShadan HussainSparsh SainiParvej KhanNilanjan Sahanull Nidhi

Published in: Expert opinion on pharmacotherapy (2024)

Findings suggest the beneficial effects of ipragliflozin on liver enzymes. Further large-scale RCTs are required to confirm ipragliflozin's role for liver-related conditions in T2DM.

Keyphrases

systematic review
type diabetes
adipose tissue
insulin resistance
weight loss
glycemic control